1. Home
  2. CCLD vs SERA Comparison

CCLD vs SERA Comparison

Compare CCLD & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$3.58

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

N/A

Current Price

$2.04

Market Cap

77.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCLD
SERA
Founded
1999
2008
Country
United States
United States
Employees
3650
N/A
Industry
Computer Software: Prepackaged Software
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
77.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CCLD
SERA
Price
$3.58
$2.04
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
413.5K
65.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.66
EPS
N/A
N/A
Revenue
N/A
$77,000.00
Revenue This Year
$11.92
$25.84
Revenue Next Year
$6.37
$715.79
P/E Ratio
$32.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$1.37
52 Week High
$4.01
$4.20

Technical Indicators

Market Signals
Indicator
CCLD
SERA
Relative Strength Index (RSI) 80.75 38.74
Support Level $2.88 $1.80
Resistance Level $3.87 $3.59
Average True Range (ATR) 0.19 0.19
MACD 0.12 0.03
Stochastic Oscillator 98.41 36.96

Price Performance

Historical Comparison
CCLD
SERA

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: